| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4423185f79003e8f9b981e29323454a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2570-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C305-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C305-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate |
2014-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6beccffb5be5001a02677e1b3f453737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fee6501c00c7bd3f9ad6014576bed9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f1c6f4800d1dce83b9b62a0e1d9bee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_752179a6d5a0498a3ad646adf1582fec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdf0e7f2d99c5cee10121012ca739e18 |
| publicationDate |
2016-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2015012490-A |
| titleOfInvention |
METABOLITES OF N- (4 - {[6,7-BIS (METILOXI) QUINOLIN-4-IL] OXI} PHENYL) -N '- (4-FLUOROPHENYL) CICLOPROPAN-1,1-DICARBOXAMIDE. |
| abstract |
The invention relates to cabozantinib (I) metabolites, as well as their uses. See formula: I. |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |